Xungene Therapeutics
Daxing · Founded 2023
About Xungene Therapeutics
Xungene Therapeutics creates RNA-targeting small molecule medicines.
Company Facts
- Founded: 2023
- Legal name: Xunjing Biotech (Beijing) Intelligent Technology Co., Ltd.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Funding stage: Seed
- Last round: Angel (Sep 2023)
Canonical: https://fsome.com/organization/xungene-therapeutics-8366205 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.